Cost-effectiveness analysis of colorectal cancer treatments

被引:24
|
作者
van den Hout, WB
van den Brink, M
Stiggelbout, AM
van de Velde, CJH
Kievit, J
机构
[1] Leiden Univ, Med Ctr, Dept Med Decis Making, NL-2300 RC Leiden, Netherlands
[2] Leiden Univ, Med Ctr, Dept Surg Oncol, NL-2300 RC Leiden, Netherlands
关键词
cost-effectiveness analysis; methodology; survey; colorectal cancer;
D O I
10.1016/S0959-8049(02)00053-9
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A concise overview is provided of the methodology of cost-effectiveness analyses, followed by a survey of published CEAs of colorectal cancer treatments. To gain credibility, the methodology applied in CEAs must be further improved. Costs are rarely estimated from the societal perspective, and little is known about how colorectal patients value their treatment and health. (C) 2002 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:953 / 963
页数:11
相关论文
共 50 条
  • [21] Cost-effectiveness analysis of single colonoscopy versus single fecal test for colorectal cancer diagnosis and treatment
    Ishibashi, Fumiaki
    Suzuki, Sho
    Kobayashi, Konomi
    Tanaka, Ryu
    Kawakami, Tomohiro
    Mochida, Kentaro
    Nagai, Mizuki
    Ishibashi, Yuichi
    Morishita, Tetsuo
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2024, 39 (07) : 1328 - 1335
  • [22] Cost-effectiveness analysis of postoperative surveillance for stage IV colorectal cancer in Japan: An economic modeling study
    Tsukamoto, Fumio
    Tsukamoto, Shunsuke
    Kato, Takeharu
    Nagata, Hiroshi
    Takamizawa, Yasuyuki
    Moritani, Konosuke
    Kinugasa, Yusuke
    Esaki, Minoru
    Kanemitsu, Yukihide
    Igarashi, Ataru
    ANNALS OF GASTROENTEROLOGICAL SURGERY, 2025,
  • [23] Cost-effectiveness analysis of XELOX for metastatic colorectal cancer based on the NO16966 and NO16967 trials
    Shiroiwa, T.
    Fukuda, T.
    Tsutani, K.
    BRITISH JOURNAL OF CANCER, 2009, 101 (01) : 12 - 18
  • [24] Cost-effectiveness analysis of XELOX for metastatic colorectal cancer based on the NO16966 and NO16967 trials
    T Shiroiwa
    T Fukuda
    K Tsutani
    British Journal of Cancer, 2009, 101 : 12 - 18
  • [25] Cost-effectiveness of colorectal cancer screening strategies: A systematic review
    Gheysariyeha, Fatemeh
    Rahimi, Farimah
    Tabesh, Elham
    Hemami, Mohsen Rezaei
    Adibi, Payman
    Rezayatmand, Reza
    EUROPEAN JOURNAL OF CANCER CARE, 2022, 31 (06)
  • [26] Cost-effectiveness of colorectal cancer screening in the average risk population
    Moshe Leshno
    Zamir Halpern
    Nadir Arber
    Health Care Management Science, 2003, 6 (3) : 165 - 174
  • [27] Cost-Effectiveness of Aspirin, Celecoxib, and Calcium Chemoprevention for Colorectal Cancer
    Squires, Hazel
    Tappenden, Paul
    Cooper, Katy
    Carroll, Christopher
    Logan, Richard
    Hind, Daniel
    CLINICAL THERAPEUTICS, 2011, 33 (09) : 1289 - 1305
  • [28] Cost-effectiveness analysis of colonoscopy and fecal immunochemical testing for colorectal cancer screening in China
    Ren, Yinan
    Zhao, Mingye
    Zhou, Dachuang
    Xing, Qian
    Gong, Fangfang
    Tang, Wenxi
    FRONTIERS IN PUBLIC HEALTH, 2022, 10
  • [29] Follow-up in colorectal cancer: cost-effectiveness analysis of established and novel concepts
    Staib, L
    Link, KH
    Beger, HG
    LANGENBECKS ARCHIVES OF SURGERY, 2000, 385 (06) : 412 - 420
  • [30] Effectiveness and cost-effectiveness of an awareness campaign for colorectal cancer: a mathematical modeling study
    Whyte, Sophie
    Harnan, Susan
    CANCER CAUSES & CONTROL, 2014, 25 (06) : 647 - 658